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Summary
Accumulation of Na+ channels at the nodes of Ran-
vier is a prerequisite for saltatory conduction. In pe-
ripheral nerves, clustering of these channels along
the axolemma is regulated by myelinating Schwann
cells through a yet unknown mechanism. We report
the identification of gliomedin, a glial ligand for neu-
rofascin and NrCAM, two axonal immunoglobulin cell
adhesion molecules that are associated with Na+
channels at the nodes of Ranvier. Gliomedin is ex-
pressed by myelinating Schwann cells and accumu-
lates at the edges of each myelin segment during de-
velopment, where it aligns with the forming nodes.
Eliminating the expression of gliomedin by RNAi, or
the addition of a soluble extracellular domain of neu-
rofascin to myelinating cultures, which caused the
redistribution of gliomedin along the internodes,
abolished node formation. Furthermore, a soluble gli-
omedin induced nodal-like clusters of Na+ channels
in the absence of Schwann cells. We propose that gli-
omedin provides a glial cue for the formation of pe-
ripheral nodes of Ranvier.
Introduction
Saltatory conduction along myelinated axons depends
on the accumulation of voltage-gated Na+ channels at
short, regularly spaced interruptions in the myelin
sheath known as the nodes of Ranvier (Waxman and
Ritchie, 1993). At the nodes, these channels are found
in a multiprotein complex that includes cell adhesion
molecules and cytoplasmic adaptor proteins (Poliak
and Peles, 2003; Salzer, 2003). Na+ channels are asso-
ciated with NrCAM and the 186 kDa isoform of neuro-
fascin (NF186) (McEwen and Isom, 2004; Ratcliffe et al.,
2001), two IgCAMs that are concentrated at the nodal
axolemma (Davis et al., 1996). The interaction between
these IgCAMs and Na+ channels occurs directly
(McEwen and Isom, 2004; Ratcliffe et al., 2001) or
through ankyrin G (Garver et al., 1997; Lemaillet et al.,
2003; Malhotra et al., 2000), an adaptor that links inte-
gral membrane proteins to the cortical cytoskeleton
and is enriched at the nodes (Kordeli et al., 1990;*Correspondence: peles@weizmann.ac.ilMohler et al., 2002). Ankyrin G binds βIV spectrin, fur-
ther anchoring the nodal Na+ channel and IgCAMs to
the axonal cytoskeleton (Berghs et al., 2000; Komada
and Soriano, 2002).
The position of the nodes is tightly regulated by the
overlying glial cells and is not intrinsically specified by
the axon (Poliak and Peles, 2003; Salzer, 2003). During
the development of peripheral myelinated nerves, Na+
channels cluster at sites adjacent to the edges of pro-
cesses extended by myelinating Schwann cells (Vab-
nick et al., 1996), indicating that these Na+ clusters are
positioned by a direct glial cell contact. This conclusion
is also supported by freeze-fracture analysis, demon-
strating that the nodal specialization is always associ-
ated with Schwann cell processes (Tao-Cheng and Ro-
senbluth, 1983). In agreement, Na+ channel clusters are
absent after ablation of Schwann cells (Vabnick et al.,
1997); they are dispersed during acute demyelination
(Arroyo et al., 2004; Craner et al., 2003; Dugandzija-
Novakovic et al., 1995), and reappear during remyelina-
tion (Dugandzija-Novakovic et al., 1995). In contrast to
the defined requirement for direct axon-glia contact for
node formation in the PNS, Na+ clustering in the CNS
might be induced by soluble factors secreted by oligo-
dendrocytes (Kaplan et al., 2001; Kaplan et al., 1997).
Whereas CNS nodes are contacted by processes of
perinodal astrocytes and NG2-positive cells (Black and
Waxman, 1988; Raine, 1984), PNS nodes are abutted
by Schwann cell microvilli that emanate from the outer
collar of the cell (Ichimura and Ellisman, 1991; Raine,
1982). These microvilli appear relatively late during the
maturation of the myelin unit and develop from an early
glial process that contacts the nodal axolemma (Ber-
thold and Rydmark, 1983; Tao-Cheng and Rosenbluth,
1983). Schwann cell microvilli contain ERM proteins
(ezrin, radixin, and moesin) (Melendez-Vasquez et al.,
2001; Scherer et al., 2001), the ezrin binding protein
EBP50 (Gatto et al., 2003), and Rho-A GTPase (Melen-
dez-Vasquez et al., 2004), as well as syndecans (Goute-
broze et al., 2003) and dystroglycan (Saito et al., 2003).
ERM-positive processes have been shown to align with
the developing nodes and thus were suggested to me-
diate axon-glia interactions necessary for the clustering
of Na+ channels (Melendez-Vasquez et al., 2001). Dis-
ruption of Schwann cell microvilli resulted in a striking
reduction in nodal Na+ channel clustering (Saito et al.,
2003).
Previous studies suggested that, during the develop-
ment of peripheral nodes, Na+ channels are recruited
to clusters of IgCAMs and ankyrin G that were first po-
sitioned by glial processes (Lambert et al., 1997). Addi-
tion of a soluble NrCAM (Lustig et al., 2001) or neuro-
fascin (Koticha et al., 2005) to myelinating dorsal root
ganglia cultures inhibits Na+ channel clustering. In vivo,
the appearance of Na+ channels and ankyrin G at the
nodes is delayed in NrCAM null mice (Custer et al.,
2003), further indicating a role for the nodal IgCAMs
in node formation. Here we report the identification of
gliomedin, a Schwann cell ligand for both neurofascin
and NrCAM that is localized to the nodal microvilli from
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216the onset of myelination. Our results suggest that f
Schwann cell-axon interactions mediated by gliomedin c
trigger the molecular assembly of the nodes of Ranvier S
in the PNS. m
I
Results d
1
Schwann Cells Exhibit Specific Binding g
Sites for Neurofascin n
The presence of neurofascin at the nodal axolemma
suggests that it may interact with a glial receptor found
Iat the adjacent Schwann cell membrane (Lambert et al.,
f1997). To test this possibility, we used the extracellular
Adomain of either the 186 kDa or 155 kDa isoforms of
sneurofascin fused to human Fc (NF155-Fc, NF186-Fc)
pin binding experiments on mixed dorsal root ganglia
f(DRG) cultures. Both neurofascin isoforms bound ex-
cclusively to S100-positive Schwann cells and not to
neurofilament-labeled axons (Figures 1A–1D). Neuro- iFigure 1. Soluble Neurofascin Binds Schwann Cells but Not Neurons
(A–D) Binding of NF186-Fc and NF155-Fc to DRG explants (in red). Cells were also labeled with antibodies to neurofilament to detect neurons
([A and C], in green) or S100 to detect Schwann cells ([B and D], in green) as indicated. Cell nuclei were labeled with DAPI ([A–H], in blue).
(E) Binding of NF155-Fc to a Schwann cell that is aligned with a neurofilament-labeled axon. An enlarged image of the cell process spiraling
around the axon is shown in the inset.
(F–H) Binding of NF155-Fc (F), NF186-Fc (G), or L1-Fc (H) to isolated rat Schwann cells. Both neurofascin isoforms bound to most, but not
all, Schwann cells in the culture.
Scale bars: 50 m (A–D), 20 m (E), 50 m (F–H).ascin binding was occasionally detected on Schwann
ells at the initial stage of axon enwrapping (Figure 1E).
imilarly, NF155-Fc and NF186-Fc also bound to pri-
ary cultured rat Schwann cells (Figures 1F and 1G).
n contrast, Schwann cells did not bind the extracellular
omain of several related IgCAMs, such as L1 (Figure
H) or contactin (data not shown). These results sug-
est that Schwann cells express a specific ligand for
eurofascin.
dentification of a Schwann Cell Ligand
or Neurofascin
rat Schwann cell cDNA library was constructed and
creened by expression cloning in order to isolate the
utative glial ligand for neurofascin. Plasmid pools made
rom this cDNA library were transfected into COS7
ells, which were subsequently screened for their abil-
ty to bind NF-Fc, as previously described (Peles et al.,
Formation of Nodes of Ranvier in the PNS
2171995). One of six positive pools was further subdivided
into smaller pools and rescreened until a single plasmid
was isolated (Figure 2A). Sequence analysis of this
cDNA clone revealed a single open reading frame of
1647 nucleotides, which encodes for a 549 amino acid
protein (Figure 2B). The predicted polypeptide has the
hallmarks of a type II transmembrane protein, contain-
ing a short (15 aa) cytoplasmic tail at its amino terminus
and a carboxy-terminal extracellular region, which in-
cludes collagen triple helix repeats (COL) and a single
olfactomedin domain (OLF; Figures 2B and 2C). This
protein, which we termed “gliomedin,” belongs to a
growing family of olfactomedin-related molecules (Bar-
embaum et al., 2000; Loria et al., 2004; Tsuda et al.,
2002). A sequence corresponding to the extracellular
domain of mouse gliomedin was also identified as a
liver cancer-related gene (CRG-L2; Graveel et al., 2003).
The presence of both OLF and COL domains in the ex-
tracellular region of gliomedin places it within a distinct
subgroup of the olfactomedin proteins, recently termed
“colmedins” (Loria et al., 2004). As expected, double
labeling of cultured Schwann cells with NF-Fc and an
antibody to gliomedin demonstrated that the extracel-
lular domain of neurofascin only bound to cells ex-
pressing gliomedin (Figure 2D). Furthermore, all the pri-
mary positive cDNA pools originating from the screen
were found to contain gliomedin, indicating that we
have isolated the main Schwann cell ligand for neuro-
fascin (data not shown).
As demonstrated by Northern blot analysis, a single
5 kb gliomedin transcript was detected in human spinal
cord, brain, placenta, and sciatic nerve, but not in other
tissues (see Figure S1 in the Supplemental Data avail-
able online). Direct comparison between the sciatic
nerve and the brain showed that the gliomedin tran-
script is much more abundant in the PNS than in the
CNS (Figure S1B). In situ hybridization of rat sciatic
nerve demonstrated a dramatic increase in the expres-
sion of gliomedin in myelinating Schwann cells during
the first postnatal week, which corresponds to the ini-
tial period of active myelination in the PNS (Figure S1C).
Gliomedin Interacts with Both Neurofascin
and NrCAM
To characterize the interaction between gliomedin and
cell adhesion molecules, we tested whether soluble Fc-
fusion proteins containing the extracellular domain of
various IgCAMs bind to cells expressing gliomedin. As
depicted in Figure 2E, soluble neurofascin (both iso-
forms) and NrCAM specifically bound to gliomedin-
expressing COS7 cells. In contrast, no binding was de-
tected when using Fc-fusion proteins containing the
extracellular domain of other IgCAMs, such as L1 and
contactin. Similar binding specificity was observed
using isolated Schwann cells or when a soluble glio-
medin was used in binding experiments to COS7 cells
expressing the different IgCAMs (data not shown). Do-
main mapping analysis using soluble Fc-fusion proteins
containing either the extracellular domain of gliomedin
(ECD-Fc), its collagen repeat (COL-Fc), or the olfac-
tomedin domain (OLF-Fc) demonstrated that the latter
mediates its interaction with neurofascin and NrCAM
(Figures 2F and 2G and data not shown). When ECD-Fc was used in binding experiments on frozen sections
of sciatic nerves, it specifically labeled the nodes of
Ranvier, where both neurofascin and NrCAM are lo-
cated (Figure 2H). Altogether, these experiments dem-
onstrate that gliomedin binds specifically to the two Ig-
CAMs that are found at the nodal axolemma.
Gliomedin Is a Novel Component of PNS
Nodes of Ranvier
The localization of gliomedin in myelinated nerves was
determined using polyclonal and monoclonal antibod-
ies to this protein in combination with antibodies to var-
ious axonal or glial markers (Figure 3). In sciatic nerve
fibers from adult rats, gliomedin antibodies labeled
short (1–2 m long) segments along the axon (Figure
3A). Double labeling using antibodies to gliomedin and
MAG (a marker for non-compact myelin) revealed that
gliomedin was localized at the node of Ranvier, as iden-
tified by the flanking paranodal loops stained for MAG
(Figure 3B). Similarly, double immunolabeling with anti-
bodies to gliomedin and Caspr, which marks the axo-
glial paranodal junction (Einheber et al., 1997), or an
antibody that recognizes both isoforms of neurofascin
and thus labels both nodes and paranodes (Schafer et
al., 2004) demonstrated that gliomedin is found only in
the nodes of Ranvier and not at the paranodes (Figures
3C–3E). The absence of gliomedin from the paranodal
junction indicates that, in adult peripheral nerves, it is
likely to interact with the 186 kDa isoforms of neurofas-
cin that is found at the nodes rather than with the para-
nodal 155 kDa isoform (Tait et al., 2000). At the nodes,
gliomedin was localized with known nodal proteins, in-
cluding Na+ channels, ankyrin G, NrCAM, and NF186
(Figures 3F–3J). Occasionally, gliomedin staining ex-
tended beyond the nodal axolemma (Figure 3I), indicat-
ing that it may be expressed in the Schwann cell micro-
villi, which fill the nodal gap and contact the nodal
axolemma in the PNS. In contrast, gliomedin was not
detected at the nodes of Ranvier in the CNS (Figures
3K–3M).
At PNS nodes, gliomedin was localized with ERM
proteins (ezrin, radixin, moesin) and claudin-2, all of
which are concentrated in the Schwann cell microvilli
(Figure 4A) (Melendez-Vasquez et al., 2001; Poliak et
al., 2002; Scherer et al., 2001). Furthermore, immu-
noelectron microscopic analysis of cross (Figures 4D
and 4E) or longitudinal (Figures 4F–4H) sections of adult
rat sciatic nerve demonstrated that gliomedin is found
along the microvilli processes. Notably, double labeling
for gliomedin and ERM proteins revealed that gliomedin
was always associated with a microvillar membrane
(data not shown). In summary, these results demon-
strate that gliomedin is a novel glial component of the
nodes of Ranvier in the PNS and suggest that it may
play a role in mediating axoglial contact as well as in
maintaining the position of the microvilli toward the
nodal axolemma.
Developmental Expression of Gliomedin
during Myelination
We next examined when gliomedin accumulates at the
node of Ranvier during the development of peripheral
nerves. Sections of rat sciatic nerves that had been col-
Neuron
218Figure 2. Identification of Gliomedin as a Glial Ligand for the Nodal IgCAMs
(A) Binding of NF-Fc to COS-7 cells transfected with one of the primary Schwann cDNA pools (1st) or a single cDNA isolated after three
additional rounds of screening (3rd).
(B) The deduced amino acid sequence of rat gliomedin (NP 852047). The transmembrane domain (green box), collagen repeats (red line on
top of sequence), and the olfactomedin domain (blue box) are highlighted.
(C) Domain organization of gliomedin (GLDN) compared to several representatives of the olfactomedin family. The olfactomedin domain is
shown as a green ellipse and the collagen-like repeat in a red square. LPHN, latrophilin (Lelianova et al., 1997); OLFM, olfactomedin (Yokoe
and Anholt, 1993); CG6867 encodes a putative transmembrane protein in Drosophila melanogaster. The gliomedin (GLDN) subgroup also
contains UNC122 and COF-1 in C. elegans.
(D) Binding of neurofascin-Fc to gliomedin-expressing Schwann cells. Isolated rat Schwann cells were allowed to bind NF155-Fc (red) and
then fixed and stained using an antibody to gliomedin (green) and Dapi (blue) to label nuclei. Neurofascin bound to the two gliomedin-
expressing cells of the four cells present in the field.
(E) Gliomedin binds to neurofascin and NrCAM but not to other IgCAMs. Binding of different Fc-fusion proteins containing the extracellular
domains of the NF155, NF186, L1, NrCAM, or contactin (Con-Fc) to COS-7 cells expressing gliomedin (upper raw; red). Expression of glio-
medin on the cell surface was detected using specific antibodies (lower raw; green).
(F) Schematic presentation of the soluble gliomedin Fc-fusion proteins. ECD, extracellular domain; COL, collagen repeats; OLF, olfactomedin
domain. The location of the Fc region is depicted as a yellow box.
(G) The OLF domain of gliomedin mediates its interaction with neurofascin. Binding of ECD-Fc, OLF-FC, or COL-Fc to COS-7 cells expressing
neurofascin (upper row; red). The expression of neurofascin in the transfected cells was determined using specific antibodies and is shown
in green in the lower panel.
(H) Binding of ECD-Fc (upper panel) and COL-Fc (Lower panel) to sections of rat sciatic nerve. The location of the paranodal junctions is
labeled with antibodies to Caspr (red).
Scale bars: 10 m (D, E, and G), 5 m (H).
Formation of Nodes of Ranvier in the PNS
219Figure 3. Gliomedin Is Localized at the Nodes of Ranvier in the PNS
(A–D) Double immunofluorescence labeling of teased adult rat sciatic nerve using an antibody to gliomedin (green in all panels) and antibodies
to neurofilaments (A), MAG (B), Caspr (C), or pan-neurofascin (D), as indicated (all in red). The pan-neurofascin antibody recognizes both
neurofascin isoforms, NF186 and NF155, that are found at the nodes and paranodal junction, respectively.
(E) Consecutive optical sections through the nodes and the paranodes of teased sciatic nerves labeled for gliomedin (green) and pan-
neurofascin (red), along with a schematic drawing showing the location of the section. Note that while both gliomedin and neurofascin are
present in the nodes, only neurofascin is found at the adjacent paranodal region.
(F–J) Higher magnification of the nodal region in teased-fiber preparations (F–I) or cross-section (J) of sciatic nerves, double-labeled with an
antibody to gliomedin (green) and Na+ channels (F and J), ankyrin G (G), NrCAM (H), or NF186 (I), as indicated (in red). Insets in panels (F)–
(H) and (J) show merged images in which the green and red channels were shifted. Note that anti-gliomedin antibodies occasionally labeled
the nodes outside the nodal axolemma (dotted line in panel [I]).
(K) Horizontal section of the ventral region of the spinal cord, including the ventral roots, was immunolabeled with an antibody to gliomedin
(green) and Caspr (red). The border between the CNS and the PNS is depicted with a dashed line. While Caspr labeled the paranodes in both
CNS and PNS, nodal labeling of gliomedin was only detected in the ventral roots and not in the spinal cord. Some weak, nonspecific staining
of gliomedin is also seen outside the nodes in the PNS.
(L–M) Higher magnification of the areas marked in panel (K).
Scale bars: 10 m (A–D), 5 m (F–H).lected from postnatal day 1 to 14 (P1–P14), were la-
beled with antibodies to gliomedin and to Na+ chan-
nels, or to Caspr (Figure 5A). Gliomedin appeared atthe node of Ranvier before Caspr accumulated at the
paranodes (Figure 5A), in accordance with previous
studies demonstrating that Caspr accumulated at the
Neuron
220Figure 4. Gliomedin Is a Component of the Nodal Schwann Cell Microvilli
(A–C) Immunofluorescence labeling of teased sciatic nerve (A and B) or cross-section (C), using an antibody to gliomedin (in green) and
antibodies to moesin (A), ezrin (B), or claudin-2 (C) as indicated (all in red).
(D–H) Immunoelectron microscopic analysis of the localization of gliomedin in adult sciatic nerve. Immunogold labeling of gliomedin on cross
(D and E) or longitudinal (F–H) sections through the nodes. Note the strong labeling of the microvilli, whereas no gold particles were detected
in the axon. Panels (F) and (H) show higher magnifications of the red squares labeled in (G). Note that the labeling obtained between the
microvilli represents the presence of gliomedin on another microvillar membrane, which is found below the plane of the section.
Scale bars: 0.5 m (D), 0.2 m (E, F, and H), 1 m (G).paranodes shortly after ankyrin G and Na+ channels t
oclustered at the nodes (Melendez-Vasquez et al., 2001).
Subsequently, gliomedin-labeled nodes were flanked d
aby one or two Caspr-positive paranodes (Figures 5A
and 5D). Double labeling for gliomedin and Na+ chan- m
dnels demonstrated that clusters of the latter always co-
localized with gliomedin (Figure 5A). As previously de- m
scribed for Na+ channels (Vabnick et al., 1996; Lambert
et al., 1997), in the first postnatal days, antibodies to P
fgliomedin labeled different intermediate forms of nodal
maturation, ranging from distant binary nodes to closer T
wbinary and finally to the mature focal nodes (Figure 5B).
At P1, we occasionally detected gliomedin-positive f
rsites that were negative for Na+ channels (Figure 5C).
Although it is not clear whether these early clusters in- n
edeed represent future nodes, they have been detected
at the edges of MBP-labeled internodes, where Na+ d
tclusters usually form. In contrast, we found that glio-
medin colocalized with neurofascin at all stages of t
mdevelopment of sciatic nerve (data not shown). Triple
immunolabeling of myelinating dorsal root ganglion ex- 6
splants with antibodies to gliomedin, MAG, and MBP
demonstrated that the accumulation of gliomedin at t
aedges of the internodes occurs with the transition be-ween ensheathment (MAG+/MBP−) and the beginning
f myelination (MAG+/MBP+) (Figure 5E). As found in
eveloping nerves, neurofascin clusters were invariably
ssociated with gliomedin during different stages of
yelination in culture (data not shown). These results
emonstrate that gliomedin accumulates at the glial
embrane that contacts the early forming node.
roper Localization of Gliomedin Is Necessary
or Node Formation
o elucidate the role of gliomedin in peripheral nerves,
e first examined whether the addition of a soluble Fc-
usion protein containing the extracellular domain of its
eceptor (i.e., NF-Fc) to myelinating cultures affected
ode formation. DRG explants were grown in the pres-
nce of NF-Fc, or only the Fc region as control, for 12
ays after the induction of myelination as described in
he Experimental Procedures. Neither Fc-fusion pro-
eins had an affect on the ability of Schwann cells to
yelinate, as determined by MBP expression (Figure
A). However, whereas gliomedin was located at both
ides of MBP-labeled segments in control cultures, in
he presence of NF-Fc, it was abnormally distributed
long the internodes (Figure 6A). The addition of NF-
Formation of Nodes of Ranvier in the PNS
221Figure 5. Gliomedin Marks the Developing Nodes
(A) Immunofluerescence labeling of longitudinal sections of 1-, 4-, 8-, 10-, and 14-day-old rat sciatic nerve with antibodies to gliomedin
(green) and Na+ channels (upper row; red) or to Caspr (lower row; red). Inset depicts another field of view.
(B) Images of developing nodes from longitudinal sections of P4 nerve double labeled with antibodies to gliomedin (left column) and Na+
channels (middle column), as indicated. The merged images are shown on the right panel of each row. Different stages, from the immature
binary form (top) to the mature focal node (bottom) are depicted.
(C) Localization of gliomedin and Na+ channels during development. Sciatic nerve sections were labeled for gliomedin and Na+ channels, and
the number of clusters containing gliomedin (Gldn), Na+ channels (NaCh), or both (Gldn/NaCh) were counted. The results are shown as a
percentage of the total count (n = 200 sites).
(D) Developmental clustering of gliomedin compared to Caspr. Sciatic nerve sections were labeled for gliomedin and Caspr, and the numbers
of sites that contained each protein alone (Caspr or Gldn) or sites containing gliomedin flanked by a single or double Caspr staining were
scored (n = 200 sites).
(E) Immunolabeling of myelinating dorsal root ganglion explants 5 days after the induction of myelination with antibodies to gliomedin (red),
MAG, and MBP as indicated in each panel. Clustering of gliomedin is detected in the cell on the right, which expresses both MAG and MBP,
but is absent from the MAG-positive cell on the left, which has not begun to express MBP. The edges of the Schwann cells are marked with
arrowheads. Scale bars: 20 m (A and E), 5 m (B).Fc resulted in the clustering of gliomedin on the outer
(abaxonal) membrane of the cell (Figure 6B), suggesting
that binding of NF-Fc caused the displacement of glio-
medin on the cell surface. This notion was further sup-
ported by the observation that similar aggregates of gli-
omedin were detected on the surface of Schwann cells
after 2 hr incubation with NF-Fc (data not shown). Theabsence of gliomedin from the nodes was accompa-
nied by a loss of axonal clustering of Na+ channels,
ankyrin G, and βIV spectrin (Figures 6A and 6C–6E). In
contrast, phosphorylated ERM proteins were still pre-
sent at nodal sites that lacked gliomedin (Figure 6F),
indicating that treatment of NF-Fc did not disrupt
Schwann cell microvilli. Furthermore, when small and
Neuron
222Figure 6. Treatment of Myelinating Cultures with NF-Fc Results in Redistribution of Gliomedin and Inhibition of Node Formation
(A) Immunofluorescence staining of myelinating DRG cultures that were grown in the presence of NF-Fc or a control Fc for 12 days, using
antibodies to gliomedin (GLDN), Na+ channels (NaCh), and MBP as indicated. Higher magnifications of the nodal areas (marked with arrow-
heads) are shown at both sides of each panel. Note that when some gliomedin was still present at the node it was associated with a small
Na+ channel cluster. Arrows in the third panel depict small clusters of gliomedin that are found along the internodes.
(B) NF-Fc causes aberrant distribution of gliomedin. (Upper panel) A myelinating Schwann cell from NF-Fc-treated culture immunolabeled
with antibodies to MBP (green) and gliomedin (red). The location of the nucleus is marked (N). (Lower panel) Inverted image of another
myelinating cell stained for gliomedin. Clusters of gliomedin are found on the outer (abaxonal) region of the myelin unit along the entire in-
ternodes.
(C) Quantification of MBP+ internodes (mean ± SD) labeled for βIV spectrin and gliomedin in control (Fc) or NF-Fc-treated cultures is shown
as a percentage of the total sites counted (n = 4; t test p < 0.006).
(D–F) Control (Fc) or NF-Fc-treated cultures were immunolabeled with antibodies to MBP, Caspr, gliomedin (GLDN), βIV-spectrin (Spec),
ankyrin G (AnkG), or phosphorylated ERM (PERM), as indicated on the left of each panel. The position of the nodes (N), paranodes (PN), and
internodes (IN) is marked with vertical lines. Scale bars: 20 m (A), 5 m (B).aberrant nodal clusters of Na+ channels were infre- t
squently detected in the NF-Fc-treated cultures, they
were always found in proximity to some residual glio- l
amedin staining (Figure 6A, arrowhead in lower panel),
demonstrating that the clustering of nodal components t
was invariably associated with the presence of glio-
medin. Double labeling for Caspr and Na+ channels or G
oβIV spectrin revealed the presence of sites that lacked
nodal components but were still flanked by Caspr (see T
mfor example Figure 6E), indicating that the effective
nodal inhibition of NF-Fc was not secondary to parano- c
Rdal abnormalities. This conclusion is further supported
by previous studies demonstrating that the nodes are C
cwell formed in several paranodal mutants (Bhat et al.,
2001; Boyle et al., 2001; Dupree et al., 1999; Gollan et f
tal., 2003) and the observation that gliomedin was local-
ized at the nodes of Ranvier in Caspr null mice (data t
inot shown). In contrast to the robust effect of NF-Fc on
the localization of gliomedin and node formation, we a
ufound that nodes were generated in myelinating DRG
cultures treated with a soluble Fc-fusion protein con- (aining the extracellular region of gliomedin (data not
hown). This result suggests that the soluble extracellu-
ar domain of gliomedin functions as the native protein
nd is sufficient for initiating node formation, an idea
hat we tested below.
liomedin Is Required for Nodal Clustering
f Neurofascin and Na+ Channels
o further determine whether the expression of glio-
edin in myelinating Schwann cells is essential for the
lustering of nodal proteins at the axolemma, we used
NA interference (RNAi) to suppress its expression.
ultures of dissociated DRG neurons and Schwann
ells were infected with retroviruses containing two dif-
erent gliomedin-RNAi or a MAG-RNAi construct as con-
rol before the induction of myelination, as described in
he Experimental Procedures. The infected cells were
dentified by the expression of GFP, which was included
s a separate transcriptional unit in the viral vector
sed. While gliomedin clusters were present in 88%
283/322) of the MBP+GFP+ internodes expressing
Formation of Nodes of Ranvier in the PNS
223MAG-RNAi, they were present in only 26% (99/372) of
the MBP+GFP+ internodes expressing gliomedin-RNAi,
demonstrating the specificity of the RNAi used. Both
gliomedin-RNAi and MAG-RNAi had no effect on the
number of MBP-labeled internodes (Figure 7 and data
not shown), indicating that neither of these genes is
required for myelination, as previously demonstrated
for MAG (Carenini et al., 1998). As depicted in Figure 7,
suppression of gliomedin’s expression by RNAi re-
sulted in the abolishment of Na+ channels and neuro-
fascin clustering at the axolemma. Importantly, Na+
channel clusters were never detected in more than 350
MBP+GFP+ internodes that lacked gliomedin, but were
present at the edges of such internodes that still ex-
pressed it. The inhibition of node formation was spe-
cific to gliomedin-RNAi, as clusters of Na+ channels
and neurofascin were present adjacent to gliomedin at
the edges of myelin internodes of noninfected cells (ar-
row in Figures 7A, 7B, 7D, and 7F), or cells expressing
MAG-RNAi (Figures 7C, 7E, and 7G). Taken together
with the inhibitory effect of NF-Fc described above, ourFigure 7. Gliomedin Is Required for Node Formation
DRG-derived Schwann cells were infected with retroviruses containing a GFP and RNAi designed to inhibit the expression of gliomedin (A,
RNAi#1; B,D,F RNAi#3 as described in experimental procedures), or myelin associated glycoprotein (MAG; C,E,G). The cells were allowed to
myelinate for 12 days and then fixed and immunolabeled with antibodies to MBP (white), gliomedin (GLDN; red) and Na+ channels (NaCh;
blue) or neurofascin (NF; blue), as indicated. The infected cells were identified by monitoring the expression of GFP (green). The right half of
the internodes of the infected cell in in panels B and c are shown at a higher magnification in D and E. Arrowheads mark the location of the
nodes at both sides of MBP-labeled internodes. Arrows in panels A,B,D,F depict the clustering of gliomedin and Na+ channels or neurofascin
at the edge of non-infected myelinating Schwann cells. Insets depict higher magnification of the indicated nodes; insets in A,D,E show images
after shifting the red and blue channels to show the labeling of the individual components, whereas the insets in F,G show the merge images.
Scale bars: 5 m.findings demonstrate that the presence of gliomedin at
the glial membrane opposing the nodes during devel-
opment is necessary for the clustering of Na+ channels
at the axolemma.
Gliomedin Induces Nodal-Like Clustering
in the Absence of Glial Cells
The interaction between gliomedin and the axonal Ig-
CAMs may provide an inductive Schwann cell signal for
the clustering of nodal components along the axo-
lemma. To test this possibility, we examined whether
the olfactomedin domain of gliomedin (OLF-Fc), which
specifically binds neurofascin and NrCAM (Figure 2),
could induce clustering of Na+ channels in isolated
DRG neurons. OLF-Fc was mixed with a Cy3-labeled
antibody to human Fc and was allowed to bind purified
DRG neurons for 30 min at 23°C. Further aggregation
of the bound OLF-Fc by incubating the cultures at 37°C
for an additional 24 hr resulted in coclustering of neuro-
fascin (Figure 8A), underscoring its role as the axonal
receptor for gliomedin. Initial clustering of neurofascin
Neuron
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(A) Soluble Fc-fusion proteins containing the olfactomedin domain of gliomedin (OLF-Fc) or the extracellular domain of IgSF4 (IgSF4-Fc) as
control were mixed with Cy3-conjugated secondary antibody to human Fc and allowed to bind to cultures of DRG neurons. After a 30 min
binding at 23°C, unbound proteins were washed away and the cultures were incubated for additional 24 hr at 37°C in growth medium before
fixing. Binding of the indicated Fc-fusion proteins is shown in the upper panels, along with immunofluorescence labeling for neurofascin
(middle panels) and the merge images (lower panels). (B) OLF-Fc treated DRG neurons were incubated for 48 hr at 37°C in growth medium
and then fixed and immunolabeled for the bound OLF-Fc (red) and with the indicated antibodies (green). The merged images are shown for
each antibody, along with images in which the green and red channels were shifted in the insets. Aggregation of gliomedin induced the
clustering of all the nodal components examined but not of Caspr or protein 4.1B. Scale bars: 5 m. (C) The number of Na+ channels,
neurofascin, ankyrin G or βIV spectrin clusters that were found adjacent to clusters of OLF-Fc or IgSF4-Fc are shown as a percentage of the
total Fc clusters counted. All values are mean ± SD (n = 3). Note that while IgSF4-Fc induced the clustering of βIV spectrin, it had no effect
on other nodal components including, Na+ channels, ankyrin G and neurofascin. (D) Gliomedin-induced clusters contained several nodal
proteins. DRG neurons were treated with OLF-Fc for 48 hr and then fixed and immunolabeled using a combination of antibodies as indicated
in each panel. Note the co-clustering of neurofascin and spectrin, neurofascin and Na+ channels, Na+ channels and spectrin, as well as
ankyrin G and spectrin at sites of gliomedin binding. Scale bars, 5 m.was already detected after incubation of the cultures m
cfor 6 hr, but was more pronounced 24–48 hr after the
binding of OLF-Fc. In contrast, clustering of neurofas- t
tcin was not detected using the extracellular domain of
IgSF4C, an IgCAM that binds neurons (Figure 8A). Re- narkably, aggregation of OLF-FC resulted in the re-
ruitment of ankyrin G, βIV spectrin, and Na+ channels
o the neurofascin clusters (Figure 8B). In contrast to
he formation of these nodal-like clusters, OLF-Fc did
ot induce the clustering of other none-nodal axonal
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toskeletal (protein 4.1B) proteins (Figure 8B). IgSF4-Fc,
which binds an unidentified neuronal receptor distinct
from neurofascin or NrCAM (I.S. and E.P., unpublished
data), induced the clustering of βIV spectrin, but not
of Na+ channels, ankyrin G, or neurofascin (Figure 8C),
suggesting that although βIV spectrin is required for
node formation (Komada and Soriano, 2002; Lacas-
Gervais et al., 2004; Parkinson et al., 2001; Yang et al.,
2004), its clustering at the axonal membrane is not suf-
ficient to induce the molecular assembly of the nodes.
Quantification of these experiments revealed that 96%
of the OLF-Fc clusters colocalized with neurofascin
clusters, 97% with ankyrin G clusters, 86% contained
Na+ channels clusters, and 98% of these sites colocal-
ized with βIV spectrin clusters, indicating that all of the
known nodal components examined were clustered by
OLF-Fc (Figure 8C). This conclusion was further sup-
ported by triple-labeling experiments demonstrating
the coclustering of neurofascin with βIV spectrin or Na+
channels, as well as of βIV spectrin with Na+ channels
or ankyrin G at sites of OLF-Fc binding (Figure 8D). In-
terestingly, when used without a secondary antibody,
OLF-Fc bound to DRG neurons, but did not induce the
formation of nodal-like clusters (data not shown). These
results demonstrate that the focal accumulation of glio-
medin on the axonal surface is sufficient to induce the
clustering of nodal components along the axon.
Discussion
In the present study, we describe the identification of
gliomedin as a glial ligand for neurofascin and NrCAM,
two axonal IgCAMs that are present at the nodes of
Ranvier and thought to define the initial site for subse-
quent assembly of Na+ channel clusters (Lambert et al.,
1997). Several lines of evidence suggest that Schwann
cell-axon interactions mediated by gliomedin and the
IgCAMs play a role in the assembly of the nodes of
Ranvier in the PNS. (1) Gliomedin is localized at the
Schwann cell microvilli that contact the nodes of Ran-
vier. (2) It is accumulated at the edges of myelinating
Schwann cells at the time the nodes are beginning to
form. (3) During development, as well as in the mature
nerve, axonal clusters containing neurofascin, Na+ chan-
nels, ankyrin G, and βIV spectrin are invariably associ-
ated with glial clustering of gliomedin. (4) Interference
of the accumulation of gliomedin at the edges of Schwann
cells during myelination in vitro was accompanied by
a substantial reduction in Na+ channel clustering. (5)
Elimination of gliomedin’s expression in myelinating
Schwann cells by RNAi abolished node formation. (6) A
soluble olfactomedin domain of gliomedin, which binds
to the IgCAMs, was sufficient to induce nodal-like clus-
ters along the axons of isolated DRG neurons. Taken
together, our findings suggest that gliomedin acts as a
local glial cue, which triggers the assembly of the
nodes of Ranvier in the PNS.
Gliomedin, an Olfactomedin Domain
Ligand for IgCAMs
The extracellular region of gliomedin contains olfac-
tomedin and collagen-like domains, both of which arefound in a variety of secreted and transmembrane pro-
teins involved in cell adhesion and extracellular matrix
interactions (Hillier and Vacquier, 2003; Loria et al.,
2004; Yokoe and Anholt, 1993; Myllyharju and Kivirikko,
2004). Proteins containing OLF domains have been
shown to play important roles in the nervous system,
yet no specific receptors for these proteins have been
identified. For example, UNC122, the C. elegans homo-
log of gliomedin, is expressed in muscles and has been
suggested to function as an adhesion molecule at the
neuromuscular synapse (Loria et al., 2004). Noelin and
tiarin, two secreted OLF proteins, have been shown to
be involved in neurogenesis of the neural crest and dor-
sal patterning of the neural tube, respectively (Barem-
baum et al., 2000; Tsuda et al., 2002). Myocilin/TIGR,
another OLF domain-containing protein, is expressed
in photoreceptor and trabecular meshwork cells in the
eye and is often mutated in progressive open angle
glaucoma, a neurodegenerative disease that is charac-
terized by a continuous loss of optic nerve axons
(Stone et al., 1997). Myocilin is also found in the basal/
abaxonal region of the myelin sheath in the PNS, where
it could participate in linking the cell to the surrounding
basal lamina and the stabilization of the myelin unit
(Ohlmann et al., 2003). We have shown that the OLF
domain of gliomedin interacts specifically with neuro-
fascin and NrCAM, but not with several related IgCAMs.
This finding provides evidence that an OLF domain-
containing protein interacts with members of the Ig-
CAM superfamily, which mediates various cell adhesion
and recognition events during the development and
maintenance of the nervous system. Interestingly, the
binding of NrCAM but not of neurofascin, to gliomedin-
expressing cells required preclustering with a second-
ary antibody (data not shown), indicating that these two
IgCAMs display different avidities toward gliomedin.
This observation may explain the previously reported
lack of NrCAM-Fc binding to Schwann cells (Lustig et
al., 2001). At present, it is not clear whether gliomedin
interacts with both IgCAMs simultaneously, or with
each one separately in vivo.
Gliomedin Is a Novel Glial Component
of PNS Nodes
By using in situ hybridization we found that gliomedin
is expressed in myelinating Schwann cells from the on-
set of myelination. The expression of gliomedin in sci-
atic nerve starts at P1 and increases thereafter, sug-
gesting that it is a myelin-related gene. Its expression
in Schwann cells is downregulated in the absence of
Oct-6 (Bermingham et al., 2002) or Krox-20 (data not
shown), both of which control the expression of myelin-
specific genes. Immunofluorescence and immunoelec-
tron microscopic analysis demonstrated that, in the adult
peripheral nerves, gliomedin is localized at the nodes of
Ranvier, where it is present along the Schwann cell
microvilli that fill the nodal gap and contact the axon.
Although not much is known about the assembly of
Schwann cell microvilli, they are thought to develop
from an early cell process that contacts the future nodal
axolemma (Berthold and Rydmark, 1983; Tao-Cheng
and Rosenbluth, 1983). The observation that gliomedin
is not solely concentrated at the axonal interface of the
Neuron
226microvilli suggests that, in addition to mediating axon- t
tglia interactions during development, it may play a role
oin maintaining the position of the microvilli toward the
inodal axolemma in the mature nerve. This notion is fur-
Ither supported by the ability of several OLF-containing
tproteins to create higher-ordered oligomers (Yokoe and
nAnholt, 1993), as well as by the presence of a collagen-
olike domain in the extracellular domain of gliomedin.
uCollagen domains are found in many extracellular ma-
ttrix proteins that play an important role in maintaining
wthe structural organization of various tissues (Mylly-
charju and Kivirikko, 2004). Indeed, we found that, while
nthe OLF domain of gliomedin binds to neurons, its COL
ndomain binds to Schwann cells (data not shown). Fu-
rture studies should determine whether, in addition to
sits ability to bind IgCAMs as reported here, gliomedin
ialso interacts with other proteins that are located at the
tmicrovilli, such as syndecans and dystroglycan (Goute-
fbroze et al., 2003; Saito et al., 2003). The possibility that
agliomedin interacts with dystroglycan is of particular in-
sterest, as the latter contains an Ig-like domain in its
sextracellular domain, and its ablation in myelinating
2Schwann cells resulted in the disruption of the microvilli
cand substantial reduction in the clustering of Na+ chan-
cnels (Saito et al., 2003).
i
WRole of Gliomedin in the Formation of Peripheral
SNodes of Ranvier
fDuring development of myelinated axons in the PNS,
aNa+ channels initially cluster at heminodes that are as-
tsociated with myelinating Schwann cells (Vabnick et al.,
e1996). These initial clusters, located at the edge of two
wneighboring cells, appear to move toward each other
suntil they fuse and form the condensed cluster found in
the mature node. Developmental analysis of the sciatic
f
nerves showed that Na+ channels and neurofascin
n
clusters were invariably associated with glial clusters
u
of gliomedin in all intermediate forms of nodal matura-
t
tion. At P1, we detected few gliomedin clusters that W
lacked Na+ channels, suggesting that gliomedin accu- g
mulates at the nodes just prior to the arrival of Na+ c
channels. The accumulation of gliomedin at these pre- s
nodal sites resembles that of neurofascin and NrCAM, c
both of which were shown to be clustered before so- m
dium channels in the PNS (Custer et al., 2003; Lambert (
et al., 1997). Analysis of myelinating DRG cultures re- m
vealed that gliomedin accumulated at the edge of c
MAG-labeled Schwann cells once they have started to r
express MBP. Na+ channel clusters always colocalized e
with clusters of gliomedin, indicating that nodal cluster- 1
ing occurs only in association with ensheathing Schwann t
cells that have already begun to myelinate. Thus, early i
on during myelination, gliomedin accumulates at the p
glial cell processes that contact the axon, where it is m
properly positioned in order to mediate axon-glia in- P
teractions during node formation. b
We demonstrated that binding and aggregation of a s
soluble olfactomedin domain of gliomedin on the sur- a
face of isolated DRG neurons induces the formation of r
nodal-like clusters containing neurofascin, Na+ chan- l
nels, ankyrin G, and βIV spectrin. These results have e
two important implications. First, they provide evidence s
ithat the clustering of the axonal IgCAMs is sufficient torigger the molecular assembly of the nodes. Second,
hey indicate that, when presented focally at both ends
f myelinating Schwann cells, gliomedin may act as an
nstructive cue for the initial clustering of the axonal
gCAMs and subsequent node formation. The latter no-
ion is further supported by the observations that elimi-
ating gliomedin’s expression by RNAi or the addition
f NF-Fc to myelinating DRG cultures, which caused an
nusual accumulation of gliomedin in aggregates on
he abaxonal surface of myelinating Schwann cells,
ere accompanied by a profound inhibition of axonal
lustering of Na+ channels, ankyrin G, βIV spectrin, and
eurofascin. Whether this inhibition is also accompa-
ied by changes in the nodal architecture will ultimately
equire ultrastructural analysis. Furthermore, the ab-
ence of neurofascin from sites that lacked gliomedin
n these cultures strongly suggests that the initial clus-
ering of the IgCAMs at the axolemma depends on the
ocal accumulation of gliomedin. These results are in
greement with recent observations describing that
oluble NF155 and NF186 inhibit node formation in sen-
ory neuron-Schwann cell cultures (Koticha et al.,
005). The role of gliomedin as an instructive Schwann
ell signal is also supported by the observation that, in
ontrast to NF-Fc, a soluble gliomedin (ECD-Fc) did not
nhibit node formation in myelinated DRG cultures.
hile NF-Fc binds and displaces gliomedin along the
chwann cell membrane, ECD-Fc interacts with neuro-
ascin and NrCAM primarily on regions of the axon that
re free of Schwann cells, where it can actually induce
heir clustering. In agreement, we found that in my-
linating cultures the added ECD-Fc was associated
ith ectopic clusters of ankyrin G at the axonal initial
egment and cell soma (data not shown).
Our results support a two-step mechanism for the
ormation of PNS nodes. In axons before myelination,
eurofascin, NrCAM, and Na+ channels are all distrib-
ted along the axolemma, while ankyrin G is found in
he cytoplasm (Davis et al., 1996; Lambert et al., 1997).
hen ensheathing Schwann cells begin to myelinate,
liomedin is accumulated at the edges of Schwann
ells, where it is focally presented to the axon. At these
ites, binding of gliomedin to neurofascin and NrCAM
auses their initial clustering into higher-ordered oligo-
ers, which facilitates the recruitment of ankyrin G
Mohler et al., 2002). In addition, binding of gliomedin
ay affect the phosphorylation of these IgCAMs on a
onserved tyrosine residue (FIGQY), which is known to
egulate their interaction with ankyrin G, and their lat-
ral mobility at the plasma membrane (Garver et al.,
997). In the second phase, these initial clusters enable
he subsequent assembly of larger complexes contain-
ng Na+ channels, as well as βIV spectrin, which in turn
rovides further linkage to the axonal cytoskeleton (Ko-
ada and Soriano, 2002; Lacas-Gervais et al., 2004;
arkinson et al., 2001; Yang et al., 2004). This resem-
les the mechanism operating during the molecular as-
embly of postsynaptic glutamatergic synapses, where
ggregation of neuroligin by focal presentation of neu-
exin induces the clustering of PSD-95, which in turn
eads to the assembly of large protein complexes (Graf
t al., 2004). At present, it is not clear whether the sub-
equent recruitment of Na+ channels to the site of the
nteraction between gliomedin and IgCAMs occurs as
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227a result of lateral diffusion of these channels along the
axolemma (Custer et al., 2003) or by specific sorting
and targeting mechanism, as has been recently shown
to regulate the accumulation of Na+ channels in the ax-
onal initial segment (Fache et al., 2004).
In the PNS, the length of the internodes and thus the
location of the nodes are intrinsically determined by
myelinating Schwann cells (Court et al., 2004; Melen-
dez-Vasquez et al., 2004). Our results suggest that
axon-glia interaction mediated by gliomedin and the Ig-
CAMs constitutes part of the mechanism by which my-
elinating Schwann cells dictate the location of the
nodes of Ranvier along these axons. Different mecha-
nisms may operate in the CNS, where nodal clustering
requires the presence of oligodendrocytes (Mathis et
al., 2001), but not of myelination (Arroyo et al., 2004). In
contrast to Schwann cells (Ching et al., 1999), mature
oligodendrocytes secrete a soluble factor that induces
the formation of nodal-like clusters in retinal ganglion
neurons (Kaplan et al., 1997, 2001). An intriguing possi-
bility raised by our findings is that the initial clustering
of these channels in the CNS by a secreted oligoden-
drocyte factor could result from its binding to the axo-
nal IgCAMs. This would then imply that the mecha-
nisms by which oligodendrocytes and myelinating
Schwann cells regulate the clustering of Na+ channels
along the axolemma might not be so different after all.
Experimental Procedures
Tissue Culture Methods
Dissociated rat DRG cultures were grown in Neurobasal medium
(Gibco) supplemented with B27 (Gibco) and 50 ng/ml NGF (Alo-
mone labs) (NB medium) for 5 days before being used in binding
experiments. Purified DRG neurons were established by treating
dissociated mixed cultures with two cycles (2 days each) of NB
medium containing 10 M uridine/10 M 5#-Fluoro 2#-deoxyuridine
(Sigma) to eliminate fibroblasts and Schwann cells. Myelinating
DRG cultures were maintained for 2 days in NB medium and then
switched to Basal Eagle’s medium (BME; Gibco) containing ITS
supplements (Sigma), 0.2% BSA, 4 g/l D-glucose, and 50 ng/ml
NGF (BN medium). Myelination was induced after an additional 10
days by the addition of 15% heat-inactivated FCS (Gibco) and 50
g/ml L-ascorbic acid (Sigma) (BNC medium). Viral infection was
carried out for 2 hr with 8 g/ml polybrene on the second, third,
and fourth days after plating with undiluted viral stock; myelination
was induced 6 days later and proceeded for an additional 12 days
before analysis.
Expression Cloning
Construction of the rat Schwann cell cDNA library and expression
cloning was done essentially as described previously (Peles et al.,
1995). One positive pool was subdivided and rescreened three ad-
ditional times until a single clone (F10) was isolated. DNA sequenc-
ing of the isolated clone was performed on both strands (GenBank
accession number AY266116).
Constructs and Antibodies
Fc-fusions containing the collagen repeats (COL, residues 138–
253) and the olfactomedin domain (OLF, residues 299–543) were
made by cloning the corresponding DNA to pSecTagA vector (Invi-
trogen), which contains the signal sequence of the κ chain of human
IgG, and then transferred to pCX-Fc (Gollan et al., 2003). NF186Fc,
L1-Fc and NrCAM-Fc (Lustig et al., 2001) were obtained from Mar-
tin Grumet. Contactin-Fc was described previously (Peles et al.,
1995). RNAi constructs for rat gliomedin (target sequence RNAi #1,
tgagcgccattctccacaa; target sequence RNAi #3, acaactctctc
tactacca) and rat MAG (target sequence, catggcgtctggtatttca) were
cloned into a modified pRETRO-SUPER vector (Brummelkamp etal., 2002) in which the puromycin resistance gene was replaced
with an EGFP (Clontech). Retroviral stocks were prepared using the
Helper virus-free Phoenix-Eco packaging cells (kindly provided by
G. Nolan, Stanford, CA).
Polyclonal antibodies to gliomedin were generated by immuniz-
ing rabbits with synthetic peptides corresponding to amino acid
residues 273–287 (CVIPNDDTLVGRA; Ab 7202) present in the extra-
cellular region of rat gliomedin. Monoclonal MAb94 antibody to gli-
omedin was generated by immunizing mice with the above extracel-
lular-containing peptide. Rabbit polyclonal and mouse monoclonal
antibodies to Caspr (Peles et al., 1997; Poliak et al., 1999), chick
anti-βIV spectrin (Komada and Soriano, 2002), and rabbit anti-
NrCAM (Lustig et al., 2001) were previously described. Pan-neuro-
fascin monoclonal antibody was obtained from Matthew Rasband
and rabbit anti-NF186 antibody from Peter Brophy. Other primary
antibodies, including rat anti-MBP (Chemicon), mouse anti-neuro-
filaments (Sigma), mouse anti-Na+ channels (Sigma), mouse anti-
MAG (clone 513; Roche), and mouse anti-ankyrin G (Santa Cruz)
were obtained from commercial sources. Cy3, Cy5, and Alexa-con-
jugated secondary antibodies were purchased from Jackson labo-
ratory and Molecular Probes, respectively.
RNA Expression Analysis
Northern blot analysis of multiple human tissues RNA samples (BD
Bioscience) was performed as previously described (Spiegel et al.,
2002) using a 1 kb fragment of human gliomedin cDNA. For rat
tissues, a blot containing total RNA from sciatic nerve and brain
was hybridized to a 964 nucleotide BglI/EcoRI DNA fragment of rat
gliomedin. In situ hybridization was performed using cRNA probe
containing the entire gliomedin cDNA as previously described
(Spiegel et al., 2002).
Immunofluorescence and Immunoelectron Microscopy
Teased sciatic nerves and frozen sections were prepared and im-
munolabeled as previously described (Poliak et al., 2002, 2003). A
detailed step-by-step protocol for tissue processing and immu-
noelectron microscopy is available upon request. Briefly, fixed tis-
sue was embedded in 7% agar noble, sectioned on a vibrotome,
infiltrated in LR Gold, and embedded in gelatine capsules, followed
by UV polymerization. Tissue sections on formvar-coated nickel
grids were blocked with 0.5 BSA, 0.5% gelatine from porcine skin,
0.1% Tween-20 in PBS, and incubated with affinity purified anti-
gliomedin antibody in the same buffer for 2 hr in room temperature.
Grids were washed seven times in PBS and incubated for 1 hr with
goat anti-rabbit IgG conjugated to 10 nm gold (1:20; Aurion). Grids
were postfixed in 2% aqueous OsO4, stained with 2% uranyl ace-
tate and Reynolds’s lead citrate, and examined using a Philips CM-
12 transmission electron microscope.
Fc-Fusion Binding, Clustering, and Perturbation Experiments
Binding experiments were performed using various Fc-fusion pro-
teins that were already incubated with Cy3-conjugated anti-human
Fc (Jackson Laboratories) as described previously (Gollan et al.,
2003). For clustering experiments, DRG neurons were grown for
12–13 days on slides coated with 100 g/ml Poly-D-lysine (Sigma)
and 10 g/ml laminin (Sigma) before binding. The neurons were
then incubated with medium containing OLF-Fc, GLDN-Fc, or
IgSF4-Fc as described above, washed once with Neurobasal me-
dium and grown for additional 48–72 hr in NB before fixing and
staining. Quantification was done from two 72 hr and one 48 hr
experiment by counting the number of OLF-FC or IgSF4-Fc sites
(1.5–4.5 m) containing Na+ channels, neurofascin, ankyrin G, or
βIV spectrin. For Fc perturbation experiments, 100 mg/ml purified
proteins were added to DRG explants with the induction of my-
elination and was replaced every second day. The cultures were
fixed and stained after additional 12–15 days.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/47/2/215/DC1/.
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